A detailed history of American Century Companies Inc transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 874,543 shares of PBYI stock, worth $2.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
874,543
Previous 738,902 18.36%
Holding current value
$2.37 Million
Previous $2.41 Million 7.39%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.25 - $4.03 $305,192 - $546,633
135,641 Added 18.36%
874,543 $2.23 Million
Q2 2024

Aug 07, 2024

BUY
$2.92 - $5.83 $1.07 Million - $2.14 Million
366,653 Added 98.5%
738,902 $2.41 Million
Q1 2024

May 14, 2024

BUY
$4.29 - $7.4 $1.34 Million - $2.3 Million
311,197 Added 509.72%
372,249 $1.97 Million
Q4 2023

Feb 13, 2024

BUY
$2.23 - $4.49 $136,145 - $274,123
61,052 New
61,052 $264,000
Q3 2019

Nov 13, 2019

SELL
$8.75 - $12.85 $894,932 - $1.31 Million
-102,278 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$12.3 - $35.76 $247,377 - $719,205
20,112 Added 24.48%
102,278 $1.3 Million
Q1 2019

May 14, 2019

BUY
$20.77 - $42.37 $1.27 Million - $2.59 Million
61,018 Added 288.53%
82,166 $0
Q4 2018

Feb 13, 2019

SELL
$20.07 - $46.7 $1.14 Million - $2.64 Million
-56,635 Reduced 72.81%
21,148 $430,000
Q3 2018

Nov 02, 2018

BUY
$41.2 - $59.85 $963,832 - $1.4 Million
23,394 Added 43.01%
77,783 $3.57 Million
Q2 2018

Aug 08, 2018

BUY
$48.3 - $68.25 $503,479 - $711,438
10,424 Added 23.71%
54,389 $3.22 Million
Q1 2018

May 03, 2018

BUY
$59.7 - $99.25 $365,662 - $607,906
6,125 Added 16.19%
43,965 $2.99 Million
Q4 2017

Feb 02, 2018

SELL
$93.85 - $132.45 $1.33 Million - $1.87 Million
-14,144 Reduced 27.21%
37,840 $3.74 Million
Q3 2017

Nov 01, 2017

BUY
$72.0 - $119.75 $3.74 Million - $6.23 Million
51,984
51,984 $6.23 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $123M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.